ARCHIVES

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves SNDA For Gardasil For Anal Cancer And Precancerous Lesions

January 28, 2011

Final Issue of ‘87

December 11, 1987

Critics Told To Back Waste Charges Or Shut Up

November 23, 1974

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

Velcade Improves Survival In Relapsed Multiple Myeloma

July 29, 2005

President, First Lady Visit Clinical Center, Hail ‘Compassion’

January 12, 1990